L2M – BioThera Solutions

We are developing a promising new technology based on extracellular vesicles (EVs, often referred to as exosomes), which are natural delivery vehicles produced by cells. These tiny particles have the potential to transform how we treat diseases by delivering therapeutic ingredients directly to where they’re needed in the body. To bring this technology to market efficiently, we’re starting with a skincare product that uses EVs to deliver anti-aging ingredients deep into the skin, offering real, science-backed results. This approach enables us to demonstrate the effectiveness of our platform, generate early revenue, create trust in this technology, and establish a solid foundation for future medical applications (i.e., infrastructure, team, etc.). The partner organization will benefit by supporting a project with immediate commercial potential and long-term impact in advanced therapeutics.

Faculty Supervisor:

Lisheng Wang

Student:

Partner:

DMZ Ventures Inc

Discipline:

Life Sciences

Sector:

Biomanufacturing; Health and Related Sciences & Technology; Pharmaceuticals

University:

University of Ottawa

Program: